Volume 114, Nº 3, March 2020
DOI: https://doi.org/10.36660/abc.20200120
SHORT EDITORIAL
Are DOACs a Good Bang for Your Buck in Atrial Fibrillation Prevention in Real-Life?
Márcio Bittencourt
Abstract
Keywords: Stroke/prevention and control; Atrial Fibrillation; Anticoagulants/administration and dosage; Varfarin/economy; Cost-Benefit Analysis.